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Abstract
Introduction Brain-derived neurotrophic factor (BDNF) was first
identified in the intervertebral disc (IVD) when its molecular
upregulation was observed in sections of nucleus pulposus
cultured under conditions of increased osmolarity. BDNF is now
known to be involved in a number of biologic functions, including
regulation of differentiation/survival of sensory neurons,
regulation of nociceptive function and central pain modulation,
and modulation of inflammatory pain hypersensitivity. In addition,
more recent investigations show that BDNF can induce the
recruitment of endothelial cells and the formation of vascular
structures. The objectives of the present study were to use
immunocytochemistry to determine the distribution of BDNF
and its receptor (BDNF-tropomyosine receptor kinase B) in the
human IVD, and to test for gene expression of BDNF and its
receptor in cultured human annulus fibrosus cells.
Methods We studied immunohistochemical localization of
BDNF and its receptor in the human annulus, quantified the
percentage of outer annulus and inner annulus cells and nucleus
cells positive for BDNF immunolocalization, and studied the
gene expression of BDNF and its receptor using microarray
analysis.
Results The percentage (mean ± standard error of the mean) of
cells positive for BDNF localization was significantly greater in
the outer annulus (32.3 ± 2.7%, n = 22) compared with either
the inner annulus (8.1 ± 1.5%, n = 6) or the nucleus (10.4 ±
2.8%, n = 3) (P < 0.0001). BDNF-receptor immunolocalization
showed a pattern similar to that of BDNF, but was not
quantitatively assessed. BDNF gene expression levels from
cultured annulus cells showed a significant positive correlation
with increasing levels of IVD degeneration (P = 0.011).
Conclusion These findings provide data on the presence of
BDNF and its receptor in the human IVD at the translational
level, and on the expression of BDNF and its receptor by
cultured human annulus cells. Our findings point to the need for
further studies to define the role of BDNF in the human IVD and
to investigate regulatory events within the disc that control the
expression of BDNF and its receptor.
Introduction
Brain-derived neurotrophic factor (BDNF) was first identified
in the intervertebral disc (IVD) when its molecular upregulation
was observed in sections of nucleus pulposus cultured under
conditions of increased osmolarity by Boyd and colleagues
[1]. BDNF is now known to be involved in a number of biologic
functions, including regulation of differentiation/survival of sen-
sory neurons, regulation of nociceptive function and central
pain modulation, and modulation of inflammatory pain
hypersensitivity.
Nerves grow into tissues in response to signaling molecules
called neurotrophins, which are involved in the survival, differ-
entiation, migration and outgrowth of neurons. We now know
that neurotrophins are expressed in non-neuronal tissues,
including the IVD [2-4]. Gigante and colleagues recently
reported the presence of nerve growth factor (NGF) mRNA,
the high-affinity tyrosine kinase A receptor and the low-affinity
p75 receptor in rounded cells in the disc annulus and nucleus
pulposus [5]. NGF and its receptors tyrosine kinase A and p75
are expressed not only in the developing nervous system, but
also in the mature adult nervous system – where they are
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particularly important because of their association of primary
nociceptive neurons. The recent review by Mendell and col-
leagues points out that in adults NGF acts as an important
intermediate in pain, contributing to peripheral and central sen-
sitization [6].
One other neurotrophin has previously been studied in the
IVD. Abe and colleagues have reported on the expression of
NGF by human IVD cells in control disc tissue in vivo and in
vitro in cells from control IVDs using immunocytochemistry [7].
NGF was found to be high in the outer annulus and in herni-
ated disc tissue. Abe and colleagues' work also demonstrated
that the proinflammatory cytokines IL-1 and TNFα had stimula-
tory effects on NGF. These authors suggested that such
actions may play a role in nerve sprouting into the IVD, and may
be associated with discogenic pain.
Ohtori and colleagues have reported on the presence of
BDNF in dorsal root ganglion neurons innervating lumbar
discs in the rat [8]. Supraspinal BDNF-tyrosine kinase recep-
tor B signaling is now known to represent a mechanism under-
lying the development of persistent pain [9,10].
Another important role for BDNF involves more recent
advances in our understanding of BDNF function. The interest-
ing studies by Kermani and colleagues have documented the
ability of BDNF to promote revascularization via endothelial
cells and hematopoietic progenitors [11]. These investigators
suggest their work with skeletal muscle and heart indicates
that the signaling pathway involving BDNF and its receptor
may also be active in modulation of angiogenesis in specific
organs in the adult. In light of the avascular status of the adult
IVD, this role merits future research.
Because of the significance of BDNF in the IVD, our objectives
in the present work were to use immunocytochemistry to
determine the distribution of BDNF and its receptor in the
human IVD, and to test for gene expression of BDNF and its
receptor in cultured human annulus fibrosus cells.
Materials and methods
Clinical study population
The experimental study of human IVD specimens was
approved prospectively by the authors' Human Subjects Insti-
tutional Review Board (protocol number 08-04-09E). The
need for informed consent was waived (since surgical IVD tis-
sue is routinely discarded at our institution). Surgeries for disc
degeneration are routine clinical practice in our hospital. The
Thompson grading system is used to score IVD degeneration
over the spectrum of stages from Thompson grade I (a healthy
disc) to discs with advanced degeneration (Thompson grade
V) [12].
Patient specimens were derived from surgical disc proce-
dures performed on individuals with herniated discs and with
degenerative disc disease. Surgical specimens were trans-
ported to the laboratory (<30 min after surgical removal) in
sterile tissue culture medium and were placed in 10% neutral
buffered formalin for no longer than 24 hours. Care was taken
to remove all granulation tissue and to sample only IVD tissue.
Donor disc specimens were obtained via the National Cancer
Institute Cooperative Human Tissue Network; they were
shipped overnight to the laboratory in sterile tissue culture
medium and were processed as described below. Procure-
ment of specimens from the Cooperative Human Tissue Net-
work was also approved via our Institutional Review Board.
Specimens were embedded in paraffin without decalcification.
Sand rat intervertebral disc tissue
Animal studies were performed following approval by the Insti-
tutional Animal Care and Use Committee. Psammomys
obesus, the sand rat, is used in our laboratory for studies of
IVD degeneration. Colony housing and animal diet descrip-
tions have been published previously [13,14].
Spines from seven animals were used in the present study of
the immunolocalization of BDNF. The spines were removed
immediately following animal euthanization, and the IVDs were
harvested, fixed in 10% neutral buffered formalin, decalcified,
and embedded in paraffin so that en face sections of the disc
could be obtained. Sections were processed for immunohisto-
chemical localization of BDNF as described below.
BDNF immunohistochemistry performed on human 
intervertebral disc tissue and determination of the 
percentage of positive cells
Paraffin sections were cut at 4 μm, collected on PLUS slides
(Allegiance, McGaw Park, IL, USA), dried at 60°C, deparaffin-
ized in xylene (Allegiance) and rehydrated through graded
alcohols (AAPER, Shelbyville, KY, USA) to distilled water.
Antigen retrieval was performed using Dako Target Retrieval
Solution, pH 6.0 (Dako, Carpenteria, CA, USA) for 20 minutes
at 95°C followed by cooling for 20 minutes. The remainder of
the procedure was performed using the Dako Autostainer Plus
(Dako) automated stainer. Endogenous peroxidase was
blocked using 3% H2O2 (Humco, Texarcana, TX, USA). Slides
were incubated for 1 hour with antihuman BDNF (clone
number 35928; R&D Systems, Minneapolis, MN, USA) at a
1:20 dilution. Mouse IgG (Dako) was used as a negative con-
trol. The secondary antibody was Dako LSAB2 biotinylated
Link for HRP/AP (Dako) for 10 minutes followed by peroxi-
dase-conjugated streptavidin (Dako) for 10 minutes and DAB
(Dako) for 5 minutes. Slides were removed from the stainer,
rinsed in water, counterstained with light green, dehydrated,
cleared and mounted with resinous mounting media.
The proportion of cells positive for BDNF localization was
determined for the outer annulus, the inner annulus and the
nucleus. For quantitation, the average total numbers of cells
scored were as follows (mean ± standard deviation): outerAvailable online http://arthritis-research.com/content/10/4/R82
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annulus, 387 ± 110 (n = 22); inner annulus, 390 ± 154 (n =
6), and nucleus, 331 ± 43 (n = 4).
BDNF immunohistochemistry performed on sand rat 
intervertebral disc tissue
Immunohistochemistry was performed as described above
with the following exceptions. The antibodies were bioti-
nylated using the Dako ARK Kit (Dako). Sections were incu-
bated with streptavidin peroxidase (Dako ARK Kit) for 15
minutes at room temperature and were then incubated in DAB
(Dako) for 5 minutes. Rinses were performed between the
application of each reagent on the AutostainerPlus using Tris-
buffered saline containing Tween-20 (Dako). Slides were
removed from the stainer, rinsed in water, counterstained with
0.03% light green (Polysciences, Warrington, PA, USA),
dehydrated cleared and mounted with Cytoseal XYL (Richard-
Allan Scientific, Kalamazoo, MI, USA).
BDNF-receptor immunolocalization
Embedding, sectioning and blocking endogenous peroxidase
using 3% H2O2 were performed as described above. Slides
were then incubated for 1 hour with rabbit antibody to tyrosine
kinase receptor B (BDNF receptor, batch number Rb68-
010906-WS; Biosensis, Flagstaff Hill, Australia) at a 1:500
dilution. Universal negative control rabbit (Dako) was used as
a negative control. The secondary antibody was Dako LSAB2
biotinylated Link for HRP/AP (Dako) for 10 minutes followed
by peroxidase-conjugated streptavidin (Dako) for 10 minutes
and DAB (Dako) for 5 minutes. Slides were removed from the
stainer, rinsed in water, counterstained with light green, dehy-
drated, cleared and mounted with resinous mounting media.
Human intervertebral disc cell culture
Annulus cells were grown in monolayer culture (seeded at
150,000 cells/well) on a Lab-Tek® Chamber Slide™ (Nunc,
Napierville, IL, USA) or in three dimensions in a collagen
sponge as previously described [15,16].
Gene expression studies
Human IVD tissue, annulus cells in a monolayer, and annulus
cells in three-dimensional culture were assayed for gene
expression using the Affymetrix microarray system (Affymetrix,
Santa Clara, CA 95051, USA). Harvested cells were placed in
extraction buffer from the PicoPure RNA Isolation Kit (Arctu-
rus, Mountainview, CA, USA), and total RNA was extracted
from the tissue using the PicoPure RNA Isolation Kit following
the manufacturer's instructions, were reverse transcribed to
double-stranded cDNA, were subjected to two rounds of tran-
scription, and were hybridized to the DNA microarray in the
Affymetrix Fluidics Station 400 (Affymetrix, Santa Clara, CA
95051, USA). Affymetrix human U133 X3P arrays were used
(Affymetrix, Santa Clara, CA 95051, USA). The GeneChip®
Operating Software Affymetrix GeneChip Operating System
(version 1.2; Affymetrix, Santa Clara, CA 95051, USA) was
used for determining gene expression levels.
Statistical analysis
The statistical analysis utilized standard methods using SAS
software (version 8.2; SAS Institute, Cary, NC, USA). Meth-
ods used included unpaired t tests and Spearman's correla-
tion statistics. P  < 0.05 was considered statistically
significant. Data are expressed as the mean ± standard error
of the mean, or mean ± standard deviation where noted.
Results
Immunohistochemical specimens used in the localization of
BDNF and of the BDNF receptor are described in Table 1.
Thirty-one IVDs from 22 subjects were evaluated; three sub-
jects were control donors, and 19 subjects were patients
undergoing disc surgery. The study design included discs
within each of the Thompson grade classifications. Since the
majority of the surgical specimens we obtain come from grade
III and grade IV discs, there were fewer grade I and grade V
discs in the present study.
BDNF immunolocalization
Immunolocalization of BDNF was greatest in the outer annulus
(Figure 1a,b). Localization of positive cells next to negative
cells was also observed in the outer annulus, the inner annulus
and the nucleus (Figure 1c to 1e; Figure 1f is a negative con-
trol). Positive and negative cells were present within small
clusters (Figure 1e). Annulus cells encapsulated by the extra-
cellular matrix also showed positive localization (Figure 2).
The proportions of BDNF-positive cells were quantitatively
determined for the outer annulus, the inner annulus and the
nucleus pulposus. The outer annulus contained an average of
32.3 ± 2.7% (n = 22) (mean ± standard error of the mean)
cells positive for BDNF, a significantly greater level than that
present in the inner annulus (8.1 ± 1.5%, n = 6) or in the
nucleus (10.4 ± 2.8%, n = 4) (P ≤ 0.01) (Figure 3). When data
for the outer annulus were assessed based on the degenera-
tive stage of the IVD (Thompson grade), no significant relation-
ship was present (Figure 4).
Sand rat lumbar IVDs sectioned en face showed a similar pat-
tern of localization of BDNF. The greatest number of positive
cells was present in the outer annulus, with fewer positive cells
as one viewed the inner annulus (Figure 5).
BDNF-receptor immunolocalization
Localization patterns were similar for the BDNF receptor to
that seen for BDNF. Both positive cells and negative cells
were present, with the greatest number of positive cells
present in the outer annulus (Figure 6). Positive cells were
occasionally present in the nucleus in human specimens. Sand
rat lumbar IVDs showed a similar localization pattern, with a
larger proportion of positive cells in the outer annulus com-
pared with the inner annulus or the nucleus (Figure 7).Arthritis Research & Therapy    Vol 10 No 4    Gruber et al.
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Gene expression of BDNF by annulus cells
The final portion of the present study looked at gene expres-
sion of BDNF by human annulus cells cultured in monolayer
and three dimensions. Annulus cells were all derived from sur-
gical patients. This experiment utilized one grade II disc
(patient aged 45 years), five grade III discs (mean patient age
38.6 years), and four grade IV discs (mean patient age 52.2
years). All cells were cultured for 10 days prior to cell harvest.
Positive expression levels were observed in all specimens for
BDNF (gene identifier NM_001709.1) per microarray analysis.
The BDNF gene expression levels correlated significantly and
in a positive manner with the Thompson disc grade for the cell
cultures (P = 0.011, r = 0.72). When expression levels in
grades II and grade III discs (the healthier discs in this evalua-
tion) were pooled and compared with mean expression levels
in grade IV discs, significantly higher expression was identified
in the more degenerate IVDs (P = 0.037; Figure 8).
Discussion
The present study presents novel immunocytochemical data
demonstrating the presence of BDNF and of BDNF receptor
in the human outer annulus, inner annulus and nucleus pulpo-
Table 1
Demographic features of specimens studied for immunocytochemical localization of brain-derived neurotrophic factor and of its 
receptor
Subject number Site Thompson score Age (years), gender Other information Herniated?
1 L4 to L5: OA, IA, nuc 1.5 45, female Cooperative Human Tissue Network 
– unknown cause of death
-
L3 to L4: OA, IA, nuc 2 -
2 L4 to L5 2 35, female Surgical specimen No
3 L4 to L5 2 32, female Surgical specimen Yes
4 L5 to S1 2 21, male Surgical specimen Yes
5 L4 to L5 2 44, female Surgical specimen Yes
6 L4 to L5 2 37, female Surgical specimen Yes
7 L4 to L5: OA, IA, nuc 2.5 40, male Cooperative Human Tissue Network 
– cause of death, myocardial infarct
-
8 L4 to L5 3 46, female Surgical specimen No
9 L3 to L4 3 53, male Surgical specimen Yes (recurrent)
10 L4 to L5 3 53, male Surgical specimen No
11 L4 to L5, L5 to S1 3 29, female Surgical specimen No
12 L4 to L5 3 54, male Surgical specimen Yes
13 L2 to L3 3 58, male Surgical specimen Yes
14 L1 to L2: OA, IA, nuc 3 33, female Cooperative Human Tissue Network 
– cause of death, pulmonary 
embolism
-
14 T12 to L1: OA, IA, nuc 3.5 -
14 L3 to L4: OA, IA, nuc 4 -
15 L1 to L2, L2 to L3, L3 to L4 4 59, female Surgical specimen No
16 L4 to L5 4 39, female Surgical specimen Yes (recurrent)
17 L5 to S1 4 48, female Surgical specimen Yes (recurrent)
18 L2 to L3, L3 to L4, L4 to L5, 
L5 to S1
4 56, female Surgical specimen No
19 L4 to L5 4 19, male Surgical specimen No
20 L3 to L4 4 78, male Surgical specimen Yes
21 L5 to S1 5 44, female Surgical specimen No
22 L5 to S1 5 39, male Surgical specimen No
IA, inner annulus; L, lumbar; nuc, nucleus; OA, outer annulus; L, lumbar.Available online http://arthritis-research.com/content/10/4/R82
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sus. Quantitative assessment of the proportion of cells posi-
tive for BDNF localization showed significantly greater
localization in the outer annulus compared with the inner
annulus or the nucleus pulposus (P ≤ 0.01). Quantitative anal-
ysis was not performed for the BDNF receptor, but qualita-
tively its localization appeared to follow a similar pattern.
BDNF and the BDNF receptor were also found to be present
in sand rat lumbar IVDs, and the immunolocalization pattern
was similar to that seen in human IVDs but with more labeled
cells present in the outer annulus. Inner annulus cell and
nucleus cells in the human IVD were found to occasionally
show positive immunolocalization, but at a significantly lower
proportion. Although there was minimal background present in
the animal tissues, it must be remembered that this portion of
our study utilized antihuman antibodies, no biochemical analy-
sis of the cross-reactivity of the sand rat substrates was car-
ried out, and a danger of some false-positive reactivity with
proteins in the sand rat IVD remains a concern that at present
cannot be discounted.
Neurotrophins are beginning to be viewed as important agents
in the IVD. Aoki and colleagues have suggested that NGF-
dependent neurons may be the nerve population responsible
for discogenic pain based on findings from studies of disc
degeneration in rats [17,18]. A study of human discs from
subjects with low back pain performed by Freemont and col-
leagues identified a positive relationship between ingrowth of
nonmyelinated, nociceptive nerves into the IVD and the pro-
duction of nerve growth factor by nearby ingrowing blood ves-
sels [19].
Figure 1
Immunolocalization of brain-derived neurotrophic factor in human  intervertebral discs Immunolocalization of brain-derived neurotrophic factor in human 
intervertebral discs. (a) Outer annulus, subject number 14, L3 to L4. 
(b) Outer annulus, subject number 4, L1 to L2. (c) Nucleus, subject 
number 14, L3 to L4 (arrow marks nearby negative cell). (d) Outer 
annulus, subject number 4, L1 to L2 (note nearby cell that does not 
show localization). (e) Inner annulus, subject number 14, a cluster of 
cells (arrow marks one of the negative cells that lies near the positive 
cells). (f) Negative control. Bars: (a) 10 μm, (b) 0.1 μm, (c) 10 μm, (d) 
10 μm, (e) 10 μm, (f) 10 μm.
Figure 2
Immunolocalization of brain-derived neurotrophic factor in annulus cells  with prominent encapsulating extracellular matrix Immunolocalization of brain-derived neurotrophic factor in annu-
lus cells with prominent encapsulating extracellular matrix. (a) 
Inner annulus, subject number 6, L4 to L5. (b) Inner annulus, subject 
number 12, L4 to L5. Bars = 10 μm.
Figure 3
Cells positive for brain-derived neurotrophic factor localization Cells positive for brain-derived neurotrophic factor localization. 
Mean percentages of cells positive for brain-derived neurotrophic fac-
tor (BDNF) localization are shown here for the outer annulus (OA, n = 
22), the inner annulus (IA, n = 6), and the nucleus (nuc, n = 4). The 
mean percentage in the OA is significantly greater than that present in 
IA or in nuc (P ≤ 0.01). Data presented as the mean ± standard error of 
the mean.Arthritis Research & Therapy    Vol 10 No 4    Gruber et al.
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Studies have recently shown production of several neuro-
trophins by IVD cells, but the mechanisms that control their
expression, and the effects these factors have on disc cells,
are poorly understood. Gigante and colleagues recently
reported the presence of NGF mRNA and the high-affinity
tyrosine kinase A receptor and the low-affinity p75 receptor in
the rounded cells in the disc annulus and nucleus pulposus
[5]. The p75 receptor is of special interest because it also has
the ability to bind to BDNF [20].
The work presented here adds to, and expands, our under-
standing of the distribution of BDNF and its receptor in the
human IVD. In addition to NGF, BDNF has recognized neuro-
protective effects [21]. There is also evidence that BDNF can
be considered a neurotransmitter and may have a role in
nociceptive transmission [22]. Work by Thompson and col-
leagues suggests that BDNF may be released from primary
sensory nociceptors with activity such as that involved with
persistent pain states and inflammatory conditions [9]. It is well
recognized that differential regulation of neurotrophin expres-
sion occurs in inflammatory states, such as in the airway,
where NGF, BDNF and neurotrophin 3 have been shown to be
elevated during inflammation [23]. Increased proinflammatory
cytokines are now well recognized during IVD degeneration
[24-27], providing support for the hypothesis that BDNF in
vivo may be produced in response to inflammatory cytokines
during IVD degeneration. Clearly the relationship of BDNF to
inflammatory cytokines in the IVD merits future research
attention.
The recent studies of by Kermani and colleagues regarding the
ability of BDNF to promote revascularization via endothelial
cells and hematopoietic progenitors are currently unexplored
in the IVD [11]. These investigators suggest that the signaling
pathway involving BDNF and its receptor may function in mod-
ulation of angiogenesis in specific organs in the adult. Since
Figure 4
Outer annulus cells positive for brain-derived neurotrophic factor locali- zation by Thompson grade Outer annulus cells positive for brain-derived neurotrophic factor 
localization by Thompson grade. Mean percentage of outer annulus 
cells positive for brain-derived neurotrophic factor (BDNF) localization 
is shown for specimens from Thompson grades I and II pooled (n = 5), 
for grade III (n = 6), and for grades IV and V pooled (n = 11). Data pre-
sented as the mean ± standard error of the mean.
Figure 5
Immunolocalization of brain-derived neurotrophic factor in sand rat  intervertebral discs Immunolocalization of brain-derived neurotrophic factor in sand 
rat intervertebral discs. (a) Immunolocalization of brain-derived neuro-
trophic factor in a lumbar sand rat intervertebral disc. OA, outer annu-
lus; IA, inner annulus; arrow, negative cell in the IA. (b) Negative 
control. Bars = 50 μm.
Figure 6
Immunolocalization of brain-derived neurotrophic factor receptor in  human intervertebral discs Immunolocalization of brain-derived neurotrophic factor receptor 
in human intervertebral discs. (a) Immunolocalization of brain-derived 
neurotrophic factor receptor in subject number 7, L4 to L5. OA, outer 
annulus. (b) Negative control. Bars = 50 μm.
Figure 7
Immunolocalization of brain-derived neurotrophic factor receptor in  sand rat intervertebral discs Immunolocalization of brain-derived neurotrophic factor receptor 
in sand rat intervertebral discs. Immunolocalization of brain-derived 
neurotrophic factor receptor in a lumbar sand rat intervertebral disc. 
OA, outer annulus. Bar = 25 μm.Available online http://arthritis-research.com/content/10/4/R82
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the adult disc is avascular, the potential of BDNF to influence
angiogenesis in the mature disc is intriguing.
Finally, the initial observations by Boyd and colleagues that
showed the upregulation of BDNF by application of increased
osmolarity remains intriguing [1], and suggests the potential
importance of the unexplored relationship between mech-
anoregulation and BDNF in the human IVD.
Conclusion
The data presented here document the presence of BDNF
and its receptor in the human IVD at the translational level, and
also show the expression of BDNF and its receptor by cultured
human annulus cells. Quantitative assessment of the
proportion of cells positive for BDNF localization showed that
the outer annulus contained a significantly larger proportion of
positive cells compared with the inner annulus or the nucleus
(P ≤ 0.01). Our findings point to the need for further studies to
define the role of BDNF in the human IVD and to investigate
regulatory events, especially those related to mechanoregula-
tion, which regulate the expression of BDNF and its receptor
in the human IVD.
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